nitrites has been researched along with Myocardial Ischemia in 49 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs." | 7.81 | Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved? ( Gönczi, M; Kaszaki, J; Kiss, A; Kohr, MJ; Kovács, M; Miskolczi, G; Murphy, E; Seprényi, G; Végh, Á, 2015) |
| "Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs." | 3.81 | Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved? ( Gönczi, M; Kaszaki, J; Kiss, A; Kohr, MJ; Kovács, M; Miskolczi, G; Murphy, E; Seprényi, G; Végh, Á, 2015) |
| "Previous studies indicate that adenosine supplementation or nitric oxide synthase (NOS) inhibition during reperfusion exert protective effects against myocardial ischemia-reperfusion (I/R) injury." | 3.74 | Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury. ( Bouhaddi, M; Davani, S; Kantelip, JP; Reyssie, H; Rochette, L; Royer, B; Vergely, C, 2007) |
| ") is thought to protect against the damaging effects of myocardial ischemia-reperfusion injury, whereas xanthine oxidoreductase (XOR) normally causes damage through the generation of reactive oxygen species." | 3.72 | Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. ( Ahluwalia, A; Benjamin, N; Bond, R; McLean, P; Uppal, R; Webb, A, 2004) |
| "There were studied 22 patients with ischemic heart disease, who performed two effort tests at 24-hour interval." | 2.71 | Ischemic preconditioning by repeated exercise tests involves nitric oxide up-regulation. ( Bódizs, G; Ilea, M; Ober, MC; Zdrenghea, D, 2003) |
| "Asymptomatic myocardial ischemia is commonly observed in patients with coronary artery disease." | 2.40 | Treatment of asymptomatic myocardial ischemia. ( Hilleman, DE; Mohiuddin, SM; Mooss, AN, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (28.57) | 18.2507 |
| 2000's | 26 (53.06) | 29.6817 |
| 2010's | 9 (18.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Buerk, DG | 1 |
| Barbee, KA | 1 |
| Jaron, D | 1 |
| Totzeck, M | 2 |
| Korste, S | 1 |
| Miinalainen, I | 1 |
| Hendgen-Cotta, UB | 2 |
| Rassaf, T | 2 |
| Chouchani, ET | 1 |
| James, AM | 1 |
| Methner, C | 1 |
| Pell, VR | 1 |
| Prime, TA | 1 |
| Erickson, BK | 1 |
| Forkink, M | 1 |
| Lau, GY | 1 |
| Bright, TP | 1 |
| Menger, KE | 1 |
| Fearnley, IM | 1 |
| Krieg, T | 1 |
| Murphy, MP | 1 |
| Wang, Y | 1 |
| Song, X | 1 |
| Yue, X | 1 |
| Su, H | 1 |
| Gu, Y | 1 |
| Bowman, L | 1 |
| Ding, M | 1 |
| Zou, B | 1 |
| Zhao, J | 1 |
| Lin, X | 1 |
| Shiva, S | 1 |
| Heusch, G | 1 |
| Kelm, M | 1 |
| Corti, P | 1 |
| Gladwin, MT | 1 |
| Kovács, M | 1 |
| Kiss, A | 1 |
| Gönczi, M | 1 |
| Miskolczi, G | 1 |
| Seprényi, G | 1 |
| Kaszaki, J | 1 |
| Kohr, MJ | 1 |
| Murphy, E | 1 |
| Végh, Á | 1 |
| McNulty, PH | 1 |
| Scott, S | 1 |
| Kehoe, V | 1 |
| Kozak, M | 1 |
| Sinoway, LI | 1 |
| Li, J | 1 |
| Kevil, CG | 1 |
| Patel, RP | 1 |
| Akinmoladun, AC | 1 |
| Obuotor, EM | 1 |
| Barthwal, MK | 1 |
| Dikshit, M | 1 |
| Farombi, EO | 1 |
| Wang, E | 1 |
| Feng, Y | 1 |
| Zhang, M | 1 |
| Zou, L | 1 |
| Li, Y | 2 |
| Buys, ES | 1 |
| Huang, P | 1 |
| Brouckaert, P | 1 |
| Chao, W | 1 |
| Maczewski, M | 1 |
| Beresewicz, A | 1 |
| Sharma, M | 1 |
| Ganguly, NK | 1 |
| Chaturvedi, G | 1 |
| Thingnam, SK | 1 |
| Majumdar, S | 1 |
| Suri, RK | 1 |
| Elfatih, A | 1 |
| Anderson, NR | 1 |
| Mansoor, S | 1 |
| Ahmed, S | 1 |
| Horton, R | 1 |
| Holland, M | 1 |
| Gama, R | 1 |
| Vardugina, NG | 1 |
| Volkova, EG | 1 |
| Orlova, NS | 1 |
| Kato, Y | 1 |
| Kijima, Y | 1 |
| Kitakaze, M | 3 |
| Minamino, T | 3 |
| Matsu-Ura, Y | 1 |
| Hashimura, K | 1 |
| Yasuda, T | 1 |
| Ueda, T | 1 |
| Mori, I | 1 |
| Hori, M | 3 |
| Webb, A | 1 |
| Bond, R | 1 |
| McLean, P | 1 |
| Uppal, R | 1 |
| Benjamin, N | 1 |
| Ahluwalia, A | 1 |
| Zdrenghea, D | 1 |
| Bódizs, G | 1 |
| Ober, MC | 1 |
| Ilea, M | 1 |
| Iida, K | 1 |
| Li, H | 1 |
| Cui, H | 1 |
| Liu, X | 1 |
| Zweier, JL | 4 |
| Ding, HL | 1 |
| Zhu, HF | 1 |
| Dong, JW | 1 |
| Zhu, WZ | 1 |
| Yang, WW | 1 |
| Yang, HT | 1 |
| Zhou, ZN | 1 |
| Shi, Y | 1 |
| Hutchins, W | 1 |
| Ogawa, H | 1 |
| Chang, CC | 1 |
| Pritchard, KA | 3 |
| Zhang, C | 1 |
| Khampang, P | 1 |
| Lazar, J | 1 |
| Jacob, HJ | 1 |
| Rafiee, P | 1 |
| Baker, JE | 3 |
| Kuralay, F | 1 |
| Altekin, E | 1 |
| Yazlar, AS | 1 |
| Onvural, B | 1 |
| Goldeli, O | 1 |
| Andreotti, F | 1 |
| Coluzzi, G | 1 |
| Lavorgna, A | 1 |
| Marzo, F | 1 |
| Di Stasio, E | 1 |
| Carrozza, C | 1 |
| Zuppi, C | 1 |
| Crea, F | 1 |
| Davani, S | 1 |
| Vergely, C | 1 |
| Royer, B | 1 |
| Bouhaddi, M | 1 |
| Reyssie, H | 1 |
| Rochette, L | 2 |
| Kantelip, JP | 1 |
| Kharlamova, NV | 1 |
| Chasha, TV | 1 |
| Shilova, NA | 1 |
| Kuz'menko, GN | 1 |
| Klimova, OI | 1 |
| van der Vliet, HJ | 1 |
| Kuenen, BC | 1 |
| Hu, A | 1 |
| Jiao, X | 1 |
| Gao, E | 1 |
| Sharifi-Azad, S | 1 |
| Grunwald, Z | 1 |
| Ma, XL | 2 |
| Sun, JZ | 1 |
| Meyer, DJ | 1 |
| Wang, P | 1 |
| Samouilov, A | 3 |
| Kuppusamy, P | 3 |
| Node, K | 1 |
| Kosaka, H | 1 |
| Komamura, K | 1 |
| Tada, M | 1 |
| Inoue, M | 1 |
| Kamada, T | 1 |
| van Jaarsveld, H | 1 |
| Schulenburg, DH | 1 |
| Sato, H | 1 |
| Asanuma, H | 1 |
| Funaya, H | 1 |
| Koretsune, Y | 1 |
| Akiyama, K | 1 |
| Kimura, A | 1 |
| Suzuki, H | 1 |
| Takeyama, Y | 1 |
| Gluckman, TL | 1 |
| Terhakopian, A | 1 |
| Katagiri, T | 1 |
| Suh, KY | 1 |
| Roseto, J | 1 |
| Bing, RJ | 1 |
| Holman, P | 2 |
| Kalyanaraman, B | 2 |
| Kouretas, PC | 1 |
| Kim, YD | 1 |
| Cahill, PA | 1 |
| Myers, AK | 1 |
| To, LN | 1 |
| Wang, YN | 1 |
| Sitzmann, JV | 1 |
| Hannan, RL | 1 |
| Griffith, OW | 1 |
| Parikh, V | 1 |
| Singh, M | 1 |
| Mooss, AN | 1 |
| Hilleman, DE | 1 |
| Mohiuddin, SM | 1 |
| Gao, F | 1 |
| Liu, GL | 1 |
| Lopez, BL | 1 |
| Christopher, TA | 1 |
| Fukuto, JM | 1 |
| Wink, DA | 1 |
| Feelisch, M | 1 |
| Shen, JG | 1 |
| Quo, XS | 1 |
| Jiang, B | 1 |
| Li, M | 1 |
| Xin, W | 1 |
| Zhao, BL | 1 |
| Giroux, M | 1 |
| Ruidavets, JB | 1 |
| Ferrières, J | 1 |
| Zhai, P | 1 |
| Eurell, TE | 1 |
| Cooke, PS | 1 |
| Lubahn, DB | 1 |
| Gross, DR | 1 |
| Clausen, P | 1 |
| Jensen, JS | 1 |
| Jensent, G | 1 |
| Feldt-Rasmussen, B | 1 |
| Lecour, S | 1 |
| Maupoil, V | 1 |
| Zeller, M | 1 |
| Laubriet, A | 1 |
| Briot, T | 1 |
| Liu, P | 1 |
| Xu, B | 1 |
| Forman, LJ | 1 |
| Carsia, R | 1 |
| Hock, CE | 1 |
| Stevens, RM | 1 |
| Jahania, MS | 1 |
| Stivers, JE | 1 |
| Mentzer, RM | 1 |
| Lasley, RD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Controlled Trial of the Effect of Remote Ischaemic Conditioning on Coronary Endothelial Function in Patients With Angina.[NCT02666235] | Phase 2 | 60 participants (Actual) | Interventional | 2011-07-31 | Completed | ||
| The Impact of Dietary Cocoa Flavanols on Cardio-pulmonary Exercise Capacity in Human.[NCT01259739] | 13 participants (Actual) | Interventional | 2010-11-30 | Completed | |||
| The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress[NCT00250185] | Phase 1 | 135 participants | Interventional | 2005-11-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for nitrites and Myocardial Ischemia
| Article | Year |
|---|---|
[Vasodilator: nitrate and nitrite].
Topics: Biomarkers; Chromatography, Gas; Dosage Forms; Drug Monitoring; Drug Therapy, Combination; Drug Tole | 2004 |
Non-enzymatic nitric oxide synthesis in biological systems.
Topics: Animals; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Heart; Hemeproteins; Hydrogen-Ion | 1999 |
Treatment of asymptomatic myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Humans; Myocardial Ischemia | 1999 |
2 trials available for nitrites and Myocardial Ischemia
| Article | Year |
|---|---|
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.
Topics: Animals; Forearm; Hindlimb; Humans; Hyperemia; Ischemic Preconditioning; Ischemic Preconditioning, M | 2014 |
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.
Topics: Animals; Forearm; Hindlimb; Humans; Hyperemia; Ischemic Preconditioning; Ischemic Preconditioning, M | 2014 |
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.
Topics: Animals; Forearm; Hindlimb; Humans; Hyperemia; Ischemic Preconditioning; Ischemic Preconditioning, M | 2014 |
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.
Topics: Animals; Forearm; Hindlimb; Humans; Hyperemia; Ischemic Preconditioning; Ischemic Preconditioning, M | 2014 |
Ischemic preconditioning by repeated exercise tests involves nitric oxide up-regulation.
Topics: Adult; Aged; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Ischemic Preconditioning, My | 2003 |
44 other studies available for nitrites and Myocardial Ischemia
| Article | Year |
|---|---|
Nitric oxide release by deoxymyoglobin nitrite reduction during cardiac ischemia: A mathematical model.
Topics: Animals; Arterioles; Blood Flow Velocity; Cell Hypoxia; Computer Simulation; Coronary Circulation; H | 2017 |
S-nitrosation of calpains is associated with cardioprotection in myocardial I/R injury.
Topics: Animals; Calpain; Cell Line; Male; Mice, Inbred C57BL; Mitochondria; Myocardial Infarction; Myocardi | 2017 |
Identification and quantification of protein
Topics: Affinity Labels; Animals; Cardiotonic Agents; Cell Membrane Permeability; Cysteine; Disease Models, | 2017 |
Protection by nitrite against the ischemic effects induced by acute myocardial infarction in mice.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Disease Models, Animal; Male; Mice; Mice, Inbred | 2017 |
Is nitrite the circulating endocrine effector of remote ischemic preconditioning?
Topics: Animals; Humans; Ischemic Preconditioning; Male; Myocardial Ischemia; Nitric Oxide Synthase Type III | 2014 |
Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved?
Topics: Administration, Intravenous; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, | 2015 |
Nitrite consumption in ischemic rat heart catalyzed by distinct blood-borne and tissue factors.
Topics: Allopurinol; Animals; Catalysis; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Glucose; G | 2008 |
Preserving vessel function during ischemic disease: new possibilities of inorganic nitrite therapy.
Topics: Acute Disease; Animals; Chronic Disease; Coronary Vessels; Humans; Myocardial Ischemia; Nitric Oxide | 2008 |
Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.
Topics: Anacardiaceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Catalase; C | 2010 |
Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Echocardiography; Electrocardiography; Guanylate Cyc | 2011 |
Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
Topics: Animals; Coronary Circulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radicals; G | 2003 |
Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery.
Topics: Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Biomarkers; CD4 Antigens; Cell Adhesion | 2003 |
An investigation of nitric oxide metabolites during symptomatic myocardial ischaemia in relation to exercise tolerance test.
Topics: Adult; Aged; Case-Control Studies; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Isch | 2003 |
[Dependence of nitric oxide level in blood on the degree of damage in coronary vessels in women younger than 55 years with ischemic heart disease].
Topics: Adult; Coronary Angiography; Coronary Vessels; Female; Humans; Middle Aged; Myocardial Ischemia; Nit | 2004 |
Roles of systemic nitric oxide metabolites for human coronary circulation.
Topics: Acetylcholine; Aorta; Cholesterol; Coronary Angiography; Coronary Circulation; Coronary Vasospasm; C | 2004 |
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage.
Topics: Animals; Cardiotonic Agents; Humans; Hydrogen-Ion Concentration; Male; Myocardial Ischemia; Myocardi | 2004 |
Xanthine oxidase catalyzes anaerobic transformation of organic nitrates to nitric oxide and nitrosothiols: characterization of this mechanism and the link between organic nitrate and guanylyl cyclase activation.
Topics: Anions; Benzaldehydes; Binding Sites; Biotransformation; Catechols; Electrochemistry; Electrodes; El | 2005 |
Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury.
Topics: Animals; Guanidines; Hypoxia; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion | 2005 |
Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90.
Topics: Animals; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Myocardial Ischemia; Nerve Tissue Proteins; N | 2005 |
Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Huma | 2006 |
Relation between nitric oxide metabolites and haemoglobin concentrations in patients with ischaemic heart disease.
Topics: Aged; Biological Availability; Female; Hematopoiesis; Hemoglobins; Humans; Male; Middle Aged; Multiv | 2007 |
Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
Topics: Adenosine; Animals; Arginine; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Enzyme Inh | 2007 |
[The levels of nitrites and medium molecular-weight molecules in the blood of neonatal infants with posthypoxic cardiopathy].
Topics: Cardiomyopathies; Female; Fetal Hypoxia; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Myo | 2007 |
[Myocardial ischaemia as a result of treatment with capecitabine].
Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Myocardial Ische | 2007 |
Tonic beta-adrenergic drive provokes proinflammatory and proapoptotic changes in aging mouse heart.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aging; Amidines; Animals; Apoptosis; Benzylam | 2008 |
Enzymatic/non-enzymatic formation of nitric oxide.
Topics: Animals; Electron Transport Complex IV; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Nitric | 1995 |
Enzyme-independent formation of nitric oxide in biological tissues.
Topics: Animals; Electron Spin Resonance Spectroscopy; Female; Heme; Hydrogen-Ion Concentration; In Vitro Te | 1995 |
Plasma nitric oxide end products are increased in the ischemic canine heart.
Topics: Animals; Arginine; Coronary Circulation; Coronary Vessels; Dogs; Hemodynamics; Myocardial Ischemia; | 1995 |
Dietary iron alters liver, erythrocyte and plasma antioxidant and nitrite levels, and also sensitizes the heart to ischemia/reperfusion.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Erythrocytes; Female; Glutathione Peroxidase; Heart; | 1997 |
Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Cerebrovascular Di | 1997 |
Production of oxidative products of nitric oxide in infarcted human heart.
Topics: Aged; Aged, 80 and over; Arteries; Coronary Angiography; Coronary Vessels; Diastole; Female; Follow- | 1998 |
Evaluation of the magnitude and rate of nitric oxide production from nitrite in biological systems.
Topics: Animals; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Kinetics; Luminescent Measure | 1998 |
Adaptation of hearts to chronic hypoxia increases tolerance to subsequent ischemia by increased nitric oxide production.
Topics: Aging; Animals; Cyclic GMP; Gene Expression Regulation, Developmental; Gene Expression Regulation, E | 1998 |
Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog.
Topics: Animals; Anticoagulants; Blood Coagulation; Coronary Vessels; Cyclic GMP; Dogs; Endothelium, Vascula | 1999 |
Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production.
Topics: Adaptation, Physiological; Animals; Chronic Disease; Cyclic GMP; Hypoxia; Myocardial Ischemia; Myoca | 1999 |
Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.
Topics: Animals; Cell Degranulation; Creatine Kinase; Female; In Vitro Techniques; Ischemic Preconditioning, | 1999 |
Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury.
Topics: Acetylcholine; Animals; Endothelium, Vascular; Glutathione; Hemodynamics; Male; Myocardial Ischemia; | 1999 |
Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia and reoxygenation.
Topics: Animals; Animals, Newborn; Annexin A5; Apoptosis; Biomarkers; Cell Hypoxia; Cells, Cultured; DNA Fra | 2000 |
Atmospheric NO, temperature and ischaemic heart disease. Study in Toulouse and its conurbation.
Topics: Air; Ammonia; France; Humans; Humidity; Myocardial Infarction; Myocardial Ischemia; Nitric Oxide; Ni | 2000 |
Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice.
Topics: Animals; Calcium; Coronary Circulation; Edema, Cardiac; Estrogen Receptor alpha; Heart Rate; In Vitr | 2000 |
Plasma concentrations of endothelial vasoactive substances in clinically healthy subjects. associations with urinary albumin excretion and ambulatory blood pressure.
Topics: Aged; Albuminuria; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Endothelin-1; Endothelium, | 2000 |
Levels of nitric oxide in the heart after experimental myocardial ischemia.
Topics: Animals; Chelating Agents; Coronary Vessels; Electron Spin Resonance Spectroscopy; Guanidines; Hemog | 2001 |
L-NAME enhances microcirculatory congestion and cardiomyocyte apoptosis during myocardial ischemia-reperfusion in rats.
Topics: Animals; Apoptosis; Blood Pressure; Cytochrome c Group; DNA Fragmentation; Enzyme-Linked Immunosorbe | 2002 |
Effects of in vivo myocardial ischemia and reperfusion on interstitial nitric oxide metabolites.
Topics: Animals; Extracellular Space; Ischemic Preconditioning, Myocardial; Microdialysis; Myocardial Ischem | 2002 |